Redhill Biopharma News

Redhill Biopharma | D: Filing D

Feb 5 08:02 ET

Redhill Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mitchell P. Kopin(4.0%),Daniel B. Asher(4.0%), etc.

Feb 2 16:15 ET

Redhill Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-CVI Investments, Inc.(5.9%),Heights Capital Management, Inc.(5.9%)

Feb 1 10:26 ET

Redhill Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Empery Asset Management, LP(3.19%),Ryan M. Lane(3.19%), etc.

Jan 8 00:00 ET

Redhill Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Jan 2 00:00 ET

Redhill Biopharma | D: Filing D

Oct 12, 2023 16:05 ET

Redhill Biopharma | D: Filing D

Aug 7, 2023 16:05 ET

Redhill Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Empery Asset Management, LP(6.12%),Ryan M. Lane(6.12%), etc.

Jan 13, 2023 08:04 ET

Redhill Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals

Jan 4, 2023 09:09 ET

Redhill Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Cosmo Pharmaceuticals N.V.(13.2%),Cosmo Technologies Ltd.(13.2%)

Mar 7, 2022 17:25 ET

Redhill Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ibex Investors LLC(0.3%),Justin B. Borus(0.3%), etc.

Jan 27, 2022 16:31 ET

Redhill Biopharma | D: Filing D

Nov 22, 2021 16:59 ET

Redhill Biopharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Jan 15, 2021 11:19 ET

Redhill Biopharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 13, 2020 09:55 ET

Redhill Biopharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Jan 27, 2020 16:27 ET

Redhill Biopharma | D: Filing D

Nov 6, 2019 14:34 ET

Redhill Biopharma | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Jun 17, 2019 17:01 ET

Redhill Biopharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 19, 2019 12:53 ET

Redhill Biopharma | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 19, 2019 09:30 ET

Redhill Biopharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 14, 2019 11:43 ET